Motor incoordination, immune deficiencies, and an increased risk of cancer are the characteristic features of the hereditary disease ataxia-telangiectasia (A-T), which is caused by mutations in the ATM gene. Through gene targeting, we have generated a line of Atm mutant mice, Atm y/y mice. In contrast to other Atm mutant mice, Atm y/y mice show a lower incidence of thymic lymphoma and survive beyond a few months of age. Atm y/y mice exhibit deficits in motor learning indicative of cerebellar dysfunction. Even though we found no gross cerebellar degeneration in older Atm y/y animals, ectopic and abnormally differentiated Purkinje cells were apparent in mutant mice of all ages. These findings establish that some neuropathological abnormalities seen in A-T patients also are present in Atm mutant mice. In addition, we report a previously unrecognized effect of Atm deficiency on development or maintenance of CD4 ؉ 8 ؉ thymocytes. We discuss these findings in the context of the hypothesis that abnormal development of Purkinje cells and lymphocytes contributes to the pathogenesis of A-T.
T
he autosomal recessive disease ataxia-telangiectasia (A-T) is characterized by the early onset of progressive ataxia, ocular telangiectasias, and susceptibility to infections and tumors (1, 2) . A-T is caused by mutations in the ATM gene (3) . The ATM protein encodes a serine͞threonine kinase and induces p53, c-Abl, and Brca1 activation after DNA damage (4) (5) (6) (7) (8) . ATMdeficient cells exhibit cell-cycle checkpoint defects, resulting in hypersensitivity to genotoxic stress (9) . However, it is less clear whether the abnormal cellular physiology of various ATMdeficient cell types also results from defective DNA repair. For example, potassium-mediated depolarization is attenuated in A-T fibroblasts (10) , and calcium mobilization and phospholipase-C␥ activation are reduced in A-T B cells after antigen receptor stimulation (11) . Altered cellular physiology may independently contribute to the clinical manifestations of A-T.
Several lines of Atm mutant mice recapitulate numerous aspects of A-T (12) (13) (14) (15) . These Atm mutant mice exhibit growth retardation, immune system defects including defects in T cell maturation, germ cell dysfunction, and increased sensitivity to ionizing radiation (IR). Although behavioral abnormalities were observed (14) , altered cerebellar histology or degeneration was not reported (12) (13) (14) (15) . The diversity of ATM mutations and the variability in the clinical progression of A-T raises questions concerning how individual ATM mutations and genetic factors contribute to the clinical severity of A-T. Likewise, independently generated Atm-deficient mice may also vary in their phenotypic manifestations, reflecting mutagenesis strategies and͞or genetic backgrounds.
Murine Atm is expressed in both embryonic and adult tissues and likely functions at multiple developmental stages (16) . It remains unclear whether Atm deficiency alters developmental processes and how this may contribute to neurodegeneration and immunodeficiency in A-T patients. Clinical studies documenting the early onset of ataxia (17) (18) (19) and early abnormalities in Purkinje cell morphology and localization (20, 21) support the hypothesis that ATM function is essential for normal cerebellar development. To further evaluate the potential Atm functions, we have generated and characterized a line of Atm mutant mice.
Materials and Methods
Generation of Atm y/y Mice. Atm genomic clones were isolated from a 129͞Sv mouse genomic library (Stratagene). Exons encoding the RAD3-and phosphatidylinositol 3-kinase-homology domains were characterized, and those encoding amino acids 7279-7818 (22) Immunohistochemistry. Mice were anesthetized and perfused with 1.5 body volumes of 4% paraformaldehyde in 100 mM phosphate buffer (pH 7.4), postfixed at 4°C for 16 h, and cryoprotected in sucrose, and 16-m parasagittal sections were cut on a cryostat. Only midsagittal sections were used. Overnight incubations were done with anti-parvalbumin (1:500; Sigma) or anti-calbindin (1:1,000; Sigma) in PBS with 5% goat serum and 0.1% Nonidet P-40 followed by a 2-h incubation with a Cy3-linked goat anti-mouse antibody (1:100; The Jackson Laboratory). Lucifer yellow dye filling was performed as described (23) , allowing 12 min for each cell to fill.
Quantitation. Using 11-mo-old littermates, the length of Purkinje cell stem dendrite prior to bifurcation and cell body size from 35 wild-type cells from two animals, and 26 Atm y/y cells from three animals were measured in photographs of dye-injected cells by a blinded observer. Molecular layer thickness was measured in Nissl-or calbindin-stained sections along the third, sixth, and ninth folia halfway down the preculminate, primary, and secondary fissures, respectively, in three nonadjacent midsagittal sections. Ectopic Purkinje cells were counted in nonadjacent midsagittal sections (8-12 sections per animal) double-labeled by calbindin immunostaining and propidium iodide. Purkinje cell numbers were counted in six to nine nonadjacent hematoxylin and eosin-stained 16-m sections in the anterior, central, and posterior lobule along the third, sixth, and ninth folia, respectively.
Results
Generation of the Atm y/y Strain. An Atm mutation, Atm y , was created by replacing the Rad-3 homology domain (corresponding to exons 50-52 of human ATM; ref. 24 ) with a neo r gene in murine ES cells (Fig. 1A) . This mutation, which is distinct from previously generated Atm mutations (see Fig. 1 A) , was transmitted into mice (Fig. 1B) . Atm ϩ/y mice appeared indistinguishable from controls; however, Atm y/y mice shared a number of characteristics previously observed in young Atm mutant mice, including growth retardation (Ϸ80% weight of wild-type), infertility, immunodeficiency, and frequent thymic lymphomas (refs. 13-15; see below). Additionally, Atm y/y ES cells were hypersensitive to IR (data not shown).
Sequence analysis of reverse transcription (RT)-PCR products from Atm y/y tissues revealed that the Atm y/y mutation allows for production of at least two alternative transcripts (Atm y transcripts I and II; Fig. 1 A) . The Atm y transcript I includes 494 bp of a reverse-oriented neo r gene, which replaces 536 bp of Atm exons 50-52. This type of transcript, a read-through of the neo r gene after a deletion͞replacement, has been previously observed (25) . In Atm y transcript I, splicing of exon 49 to this exogenous exon results in a frameshift and a stop codon (Fig. 1 A) . In Atm y transcript II, exon 49 is directly spliced to exon 53, leading to an in-frame fusion, theoretically allowing for production of an Atm y protein with an intact phosphatidylinositol 3-kinase domain. Although these aberrant transcripts can be detected by RT-PCR in Atm y/y tissues, full-length Atm y transcripts were not detectable by Northern blot analysis (Fig. 1C) . Furthermore, neither fulllength nor partial Atm-immunoreactive protein bands were detected in the Atm y/y tissues by using either N-terminal or C-terminal antibodies (Fig. 1 D- G; see legend); although we Tumorigenesis and Lifespan. Long-term assessment of previously generated Atm mutant mice was compromised by early development of thymic lymphomas, causing death uniformly by 4 or 5 mo of age (13) (14) (15) . Atm y/y mice also succumb to thymic lymphomas; however, over 50% survived for 10 mo or more (Fig.  1H ). Based on surface marker expression, lymphomas in Atm y/y mice were generally T cell lineage in origin (data not shown), as observed previously for other Atm mutant mice (13) (14) (15) . Of note, it was recently demonstrated that breeding an Atm-deficient line into a recombinase activating gene-1 (RAG-1)-deficient background prevented the formation of T cell lymphomas in that line and resulted in increased survival (32) .
Abnormalities of the Immune System. As previously reported for other strains of Atm-deficient mice, we observed a disproportionate reduction (Ϸ40-50% of normal levels) in thymocyte and splenocyte numbers, as compared with the Ϸ20% reduction in body weight, in Atm y/y mice ( Fig. 2A) . To identify defects in Atm y/y lymphocyte development, we examined thymocyte subsets by flow cytometry (Fig. 2 B and C) . This process, as well as expansion of DP cell numbers and initiation of TCR␣ gene rearrangement, requires signaling by the pre-TCR complex (composed of pre-T␣ chains, TCR␤, and CD3), which is expressed at low levels on ''early'' DP (CD3 low DP) thymocytes (26) . Following TCR␣ gene rearrangement and expression in DP thymocytes, CD3 surface expression increases during the transition of CD3 low DP cells to CD3 int cells, which express CD3 in the context of ␣␤TCR. Such CD3 int DP cells can undergo negative selection or programmed cell death; alternatively, they can be rescued by positive selection and mature into single positive (SP) thymocytes and peripheral T cells that express higher levels of CD3͞␣␤TCR receptors (26) .
Our preliminary studies revealed no obvious abnormalities with respect to the various DN subpopulations in Atm y/y vs. wild-type mice, as judged by expression of the CD25 and CD44 surface markers (W.S. and Y.G., unpublished data). However, there was a 2-fold decrease in DP thymocyte numbers and a 5-fold decrease in SP thymocyte numbers in Atm y/y thymuses (Fig. 2B) . These findings generally agree with previous studies that implicated a defect in maturation of DP to SP thymocytes in association with the Atm deficiency (13) (14) (15) . To further pinpoint the developmental stage disrupted by the Atm y mutation, we carefully analyzed CD3 expression in the different DP and SP populations. Strikingly, the majority of Atm y/y DP thymocytes expressed low CD3 levels, in contrast to intermediate CD3 levels expressed by the majority of wild-type or heterozygous DP cells ( Fig. 2C ; confirmed by specific gating, data not shown). Scatter analyses of individual populations of Atm y/y and wild-type DP thymocytes revealed no major differences in cell size (Fig. 2C) . Furthermore, despite decreased numbers, gating on SP thymocytes in Atm y/y mice demonstrated wild-type levels of CD3 expression (data not shown), indicating that they had undergone positive selection. Likewise, although splenic T cell numbers were reduced by approximately 8-to 10-fold, their surface phenotype appeared normal (Fig. 2 A and D) .
As previously observed in other Atm mutant mice (15) , the precursor B cell and immature B cell populations were decreased in bone marrow of Atm y/y mice, but the numbers of B220-positive and IgM-positive splenic B cells were relatively similar (data not shown). Thus, as previously observed in A-T patients and Atm mutant mice (13-15, 27, 28) , the accumulation of splenic T cells in Atm y/y mice appears more profoundly affected than that of B cells (Fig. 2D) .
Motor Coordination Deficits. A-T patients suffer from the onset of ataxia during the first few years of life, suggesting that cerebellar function may be compromised prior to Purkinje cell degeneration (17) (18) (19) . Although Atm y/y mice from 4 to 12 months of age tend to explore an open field less than controls [grids crossed by wild-type (n ϭ 10) ϭ 101 Ϯ 47 and Atm y/y (n ϭ 17) ϭ 67 Ϯ 41, P ϭ 0.062 by a two-sided t test, see also ref. 14], they do not exhibit ataxia as assessed by paw-prints and bridge crossing (data not shown). As a more sensitive assay of cerebellar function, we tested motor learning on an accelerating rotating rod (Fig. 3A) . On the first trial day, Atm y/y mice (n ϭ 13) performed as well as wild-type mice (n ϭ 9). However, unlike wild-type mice, Atm y/y mice failed to improve with repeated trials. After 1 wk of daily training, wild-type mice were performing significantly better than Atm y/y mice (Fig. 3A) . Thus, 4-to 12-mo-old Atm y/y mice display mild deficits in motor learning consistent with cerebellar dysfunction.
Cerebellar Pathology. The cerebellar cortex consists of three layers: an outer molecular layer containing Purkinje cell dendrites arranged in parasagittal fans, a single cell layer of Purkinje cell bodies, and the internal granule cell layer containing the small granule neurons. Immunostaining of Purkinje cells with an anti-calbindin antibody and Bodian staining of midsagittal cer- (Fig. 3 B and C , nine age-matched pairs examined). To visualize individual dendritic trees, the fluorescent dye Lucifer yellow was injected into individual Atm y/y and wild-type Purkinje cells of 11-mo-old littermates. As shown, the stem dendrites, which extend from the cell body to the first bifurcation, consistently branch prematurely in Atm y/y mice (Fig. 3 D-G , average length in ϭ 16.1 Ϯ 3.6 m; wild-type ϭ 33.0 Ϯ 3.6 m, P Ͻ 0.002 by two-sided t test). In addition, dye-injected Atm y/y Purkinje cells often had multiple dendrites originating directly from the cell bodies (Fig. 3D) Purkinje cell axons in the internal granule cell layer (Fig. 4C) . These axonal swellings are small (Ͻ5 m in diameter), similar in appearance to those seen during Purkinje cell development (29) , and unlike the large axonal torpedoes seen in A-T (1). Further axonal abnormalities in the white matter tracks and deep nuclei were not detected.
These cerebellar abnormalities could reflect either developmental or degenerative changes. However, abnormal Purkinje cell morphology as assayed by immunohistochemistry (data not shown) reduced molecular layer thickness [wild-type, 171 Ϯ 10 m (n ϭ 2) and Atm at a normal density in 11-to 12-mo-old Atm y/y mice ( Fig. 4C and Table 1 ), and there was no appreciable increase in the size or number of axonal varicosities in older animals. Thus, the early appearance of abnormal histology and the lack of Purkinje cell loss suggest that cerebellar architecture is disrupted during development in Atm y/y mice. mice are growth-retarded, infertile, immunodeficient, and prone to develop thymic lymphomas, attributes similar to those reported for other Atm mutant lines (12) (13) (14) (15) . However, in these previous lines (14, 15) , altered cerebellar histology has not been reported, even though behavioral abnormalities were observed (14) . In contrast, the Atm (Fig. 1 A) . In A-T patients, ATM protein fragments are not found in those patients harboring nonsense mutations (33) . However, ATM protein products have been detected in A-T patients with missense mutations or in-frame deletions (33, 34) , and we did detect a slow-migrating Atm immunoreactive protein in one Atm y/y ES cell line (data not shown). Yet, we did not detect Atm immunoreactive proteins (using both N-terminal and C-terminal antibodies) in the developing cerebellum and thymus of Atm y/y mice. Thus, while it is possible that a residual amount of aberrant Atm y protein could have eluded detection by our methods, it would appear that in vivo expression of such a putative protein is, at most, very low.
Discussion
Atm y/y mice have motor-learning deficits and histological changes in the cerebellum that recapitulate some of the abnormalities seen in A-T patients at early disease stages (20, 21) . In particular, abnormal dendritic arborization (Fig. 3) and the presence of ectopic Purkinje cells (Fig. 4) , together with a thin molecular layer, are present in Atm y/y mice from age 6 wk to 12 mo. Abnormalities in Purkinje cell localization and morphology in A-T patients could arise early during cerebellar development (21) . Alternatively, these could be early manifestations of degeneration (35) . We found that ectopic Purkinje cells and reduced molecular layer thickness are apparent in Atm y/y animals at 6 wk of age and do not progress during a year of life. Thus, the neuroarchitectural changes in Atm y/y mice and A-T patients likely reflect altered dendritic arborization during Purkinje cell differentiation, rather than dendrite retraction and degeneration. These dendritic changes could explain our behavioral data in Atm y/y mice (Fig. 3A) since dendritic integration of afferent stimuli may be related to arborization (36) . Curiously, Atm, which is primarily a nuclear protein in dividing cells (37) (38) (39) (40) , is localized in the cytoplasm and proximal dendrites of developing and mature Purkinje cells (41) , suggesting potential functions outside the nucleus during Purkinje cell maturation.
Atm y/y Mice Have a Defect in Thymocyte. Consistent with other Atm-deficient mice (13) (14) (15) , Atm y/y mice have decreased numbers of SP thymocytes and mature T lymphocytes (Fig. 2) . However, we find that the population of CD3 int cells found in normal mice is drastically reduced in Atm y/y mice, with most Atm y/y DP cells expressing low CD3 levels (Fig. 2C) . Therefore, our findings indicate that the major thymocyte developmental defect in Atm y/y mice is within the development or maintenance of DP thymocytes, as opposed to the transition from DP to SP thymocytes, as previously suggested for other mutant strains (13) (14) (15) . However, the mechanism by which Atm deficiency affects DP thymocyte populations remains speculative.
The well-established requirement for ATM in multiple cellcycle checkpoints raises the possibility that Atm might be involved in CD3 int DP cell survival (26, 42) . Another possibility is that CD3 int DP cell loss in Atm y/y mice is due to down-regulation of TCR expression by means of an unknown mechanism. An intriguing possibility is a role for ATM in V(D)J recombination. However, transient recombination substrate studies in A-T cell lines have indicated that ATM does not participate directly in V(D)J recombination (43) . In this context, Atm y/y mice generate substantial DP cell numbers (implying substantial TCR␤ gene rearrangement), and our preliminary analyses revealed significant levels of TCR␣ rearrangements in Atm y/y thymocytes (data not shown). Still, it has not been determined whether the absolute rate of such chromosomal V(D)J rearrangements is equivalent to that of wild type. Therefore, while ATM is not required for V(D)J recombination per se, it may have some indirect influence on the process, a possibility consistent with the high rates of chromosomal translocations involving TCR loci in human A-T lymphocytes (27) . In this regard, the Atm y/y phenotype, while less severe, is reminiscent of the phenotype of TCR␣ enhancer knockout mice (44) . The latter mice have normal V(D)J recombination activity but, because of accessibility problems at TCR␣ locus, have reduced levels of TCR␣ gene rearrangement accompanied by relatively normal numbers of thymocytes, of which most are CD3 low DP cells. Finally, another V(D)J recombination-related mechanism would involve deregulation of this activity during the cell cycle (42) .
Potential Role of Atm in Development. The similarity between the Purkinje cell and lymphocyte abnormalities in Atm y/y mice and Vermial area was the same in both genotypes (ratio of wild-type/Atm y/y area ϭ 0.99).
those observed in A-T patients suggest that the consequences of ATM deficiency in mice and humans are substantially similar. Previous work implicated Atm in the regulation of IR-induced apoptosis in central nervous system (CNS) neuroblasts and DP thymocytes via a p53-dependent process (12, 15) . However, other studies showed that p53 deficiency does not result in the same thymocyte and CNS developmental defects that we see in Atm y/y mice (45, 46) . In addition, individuals harboring hypomorphic mutations in Mre11 display A-T-like clinical manifestations and cellular defects, and yet maintain a normal p53 response (47) . Therefore, Atm may have developmental functions separate from functions in the context of p53. This notion also raises the possibility that at least some cerebellar abnormalities resulting from loss of Atm function occur during development, rather than as a result of degeneration later in life. In the latter context, it will be of interest to determine whether the thymocyte developmental anomalies of Atm y/y mice contribute to generation of thymic lymphomas.
